| Lastest Insider Transactions Of VERTEX PHARMACEUTICALS INC / MA ( VRTX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | SVP & Chief Accounting Officer | 2024-04-01 | Sell | 240 | 419.00 | 100,560 | 2024-04-03 16:02:22 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2024-02-23 | Sell | 354 | 425.70 | 150,698 | 2024-02-27 17:02:56 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP Chief Patient & Ext Af Off | 2024-02-23 | Sell | 3,004 | 425.70 | 1,278,803 | 2024-02-27 16:59:03 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | 2024-02-23 | Sell | 883 | 425.70 | 375,893 | 2024-02-27 16:44:07 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | 2024-02-23 | Sell | 5,034 | 425.70 | 2,142,974 | 2024-02-27 16:37:27 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | SVP & Chief Accounting Officer | 2024-02-23 | Sell | 883 | 425.70 | 375,893 | 2024-02-27 16:29:19 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | 2024-02-23 | Sell | 4,239 | 425.70 | 1,804,542 | 2024-02-27 16:24:03 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2024-02-21 | Sell | 360 | 421.77 | 151,837 | 2024-02-23 16:28:11 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | 2024-02-21 | Sell | 1,201 | 421.77 | 506,546 | 2024-02-23 16:16:13 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | 2024-02-21 | Sell | 3,603 | 421.77 | 1,519,637 | 2024-02-23 16:12:34 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | 2024-02-21 | Sell | 3,002 | 421.77 | 1,266,154 | 2024-02-23 16:10:15 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2024-02-16 | Sell | 480 | 420.79 | 201,979 | 2024-02-21 16:43:13 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP Chief Patient & Ext Af Off | 2024-02-16 | Sell | 4,254 | 420.79 | 1,790,041 | 2024-02-21 16:38:30 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | 2024-02-16 | Sell | 801 | 420.79 | 337,053 | 2024-02-21 16:23:49 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | 2024-02-14 | Sell | 9,011 | 419.10 | 3,776,528 | 2024-02-16 16:07:03 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | 2024-02-12 | Sell | 3,393 | 419.42 | 1,423,104 | 2024-02-14 16:04:31 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP Chief Patient & Ext Af Off | 2024-02-09 | Sell | 3,222 | 420.24 | 1,354,013 | 2024-02-13 17:15:30 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Biller Jonathan | EVP and Chief Legal Officer | 2024-02-09 | Sell | 1,738 | 418.77 | 727,822 | 2024-02-13 16:56:51 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | 2024-02-09 | Sell | 913 | 420.24 | 383,679 | 2024-02-13 16:54:16 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | 2024-02-09 | Sell | 4,295 | 420.24 | 1,804,931 | 2024-02-13 16:51:40 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | SVP & Chief Accounting Officer | 2024-02-09 | Sell | 1,374 | 420.24 | 577,410 | 2024-02-13 16:48:51 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | 2024-02-09 | Sell | 3,145 | 420.24 | 1,321,655 | 2024-02-13 16:46:04 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | 2024-01-08 | Sell | 6,648 | 419.07 | 2,785,977 | 2024-01-10 16:06:40 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2024-01-02 | Sell | 3,000 | 405.00 | 1,215,000 | 2024-01-04 16:17:23 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | 2023-12-15 | Sell | 17,135 | 407.00 | 6,973,945 | 2023-12-19 16:15:42 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | 2023-12-15 | Option Exercise | 17,135 | 181.83 | 3,115,593 | 2023-12-19 16:15:42 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | 2023-12-13 | Sell | 13,354 | 399.42 | 5,333,799 | 2023-12-15 16:33:17 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | 2023-12-13 | Sell | 5,098 | 397.00 | 2,023,906 | 2023-12-15 16:23:03 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | 2023-12-13 | Sell | 8,603 | 399.00 | 3,432,597 | 2023-12-15 16:20:23 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | 2023-12-13 | Option Exercise | 8,603 | 187.53 | 1,613,321 | 2023-12-15 16:20:23 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-11-20 | Sell | 3,000 | 349.88 | 1,049,640 | 2023-11-21 16:07:18 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP Chief Patient & Ext Af Off | 2023-11-15 | Sell | 35 | 369.92 | 12,947 | 2023-11-17 16:16:41 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | 2023-11-15 | Sell | 19 | 369.92 | 7,028 | 2023-11-17 16:11:06 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | 2023-11-14 | Sell | 5,650 | 380.82 | 2,151,633 | 2023-11-16 16:15:32 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | 2023-11-13 | Sell | 5,097 | 377.00 | 1,921,569 | 2023-11-15 16:16:04 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | SACHS BRUCE I | Directior | 2023-11-06 | Sell | 11,250 | 385.00 | 4,331,250 | 2023-11-08 16:11:25 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | SACHS BRUCE I | Directior | 2023-11-06 | Option Exercise | 11,250 | 127.54 | 1,434,825 | 2023-11-08 16:11:25 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | 2023-10-31 | Sell | 5,651 | 355.92 | 2,011,304 | 2023-11-02 16:07:20 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | 2023-10-17 | Sell | 5,651 | 373.25 | 2,109,236 | 2023-10-19 16:18:28 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Bhatia Sangeeta N. | Directior | 2023-10-17 | Sell | 243 | 375.00 | 91,125 | 2023-10-19 16:13:25 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | 2023-10-16 | Sell | 12,962 | 374.00 | 4,847,788 | 2023-10-18 16:17:15 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Bhatia Sangeeta N. | Directior | 2023-10-06 | Sell | 242 | 360.00 | 87,120 | 2023-10-11 16:14:06 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | 2023-10-03 | Sell | 5,651 | 345.28 | 1,951,177 | 2023-10-05 16:30:27 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Biller Jonathan | EVP and Chief Legal Officer | 2023-09-29 | Sell | 610 | 346.76 | 211,524 | 2023-10-03 16:07:56 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | 2023-09-19 | Sell | 5,651 | 351.00 | 1,983,501 | 2023-09-21 16:15:36 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | 2023-09-05 | Sell | 5,651 | 352.66 | 1,992,882 | 2023-09-07 16:29:38 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2023-08-23 | Sell | 2,500 | 355.00 | 887,500 | 2023-08-25 16:14:50 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kearney Terrence C | Directior | 2023-08-10 | Sell | 10,000 | 350.00 | 3,500,000 | 2023-08-14 16:09:17 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kearney Terrence C | Directior | 2023-08-10 | Option Exercise | 10,000 | 127.54 | 1,275,400 | 2023-08-14 16:09:17 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2023-08-10 | Sell | 5,750 | 345.79 | 1,988,293 | 2023-08-14 16:08:52 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP, Chief Patient Officer | 2023-08-10 | Sell | 10,031 | 350.00 | 3,510,850 | 2023-08-14 16:05:14 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | 2023-08-09 | Sell | 63 | 345.51 | 21,767 | 2023-08-11 16:05:13 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Bhatia Sangeeta N. | Directior | 2023-08-09 | Sell | 242 | 345.51 | 83,613 | 2023-08-11 16:05:08 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | SACHS BRUCE I | Directior | 2023-07-14 | Sell | 11,250 | 356.75 | 4,013,459 | 2023-07-18 16:17:01 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | SACHS BRUCE I | Directior | 2023-07-14 | Option Exercise | 11,250 | 127.54 | 1,434,825 | 2023-07-18 16:17:01 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | 2023-07-17 | Sell | 7,828 | 355.00 | 2,778,940 | 2023-07-18 16:13:37 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | 2023-06-15 | Sell | 8,603 | 349.00 | 3,002,447 | 2023-06-20 16:07:09 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | 2023-06-15 | Option Exercise | 8,603 | 187.53 | 1,613,321 | 2023-06-20 16:07:09 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | 2023-05-30 | Sell | 82 | 329.82 | 27,045 | 2023-06-01 16:16:50 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | SVP & Chief Accounting Officer | 2023-05-30 | Sell | 289 | 329.82 | 95,318 | 2023-06-01 16:12:55 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-05-05 | Sell | 3,272 | 350.00 | 1,145,213 | 2023-05-09 16:15:20 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | 2023-05-05 | Sell | 2,004 | 349.25 | 699,887 | 2023-05-09 16:10:59 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-05-02 | Sell | 4,403 | 350.71 | 1,544,187 | 2023-05-04 16:51:48 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | 2023-05-02 | Sell | 10,958 | 349.98 | 3,835,062 | 2023-05-04 16:50:03 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Bhatia Sangeeta N. | Directior | 2023-05-01 | Sell | 580 | 348.28 | 202,004 | 2023-05-03 16:44:20 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | 2023-04-27 | Sell | 3,317 | 339.08 | 1,124,726 | 2023-05-01 16:26:35 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-04-12 | Sell | 7,567 | 326.70 | 2,472,164 | 2023-04-14 16:19:24 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | SACHS BRUCE I | Directior | 2023-04-12 | Sell | 21,300 | 326.73 | 6,959,422 | 2023-04-14 16:14:39 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | SACHS BRUCE I | Directior | 2023-04-12 | Option Exercise | 21,300 | 72.14 | 1,536,582 | 2023-04-14 16:14:39 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-04-04 | Sell | 522 | 315.81 | 164,854 | 2023-04-06 16:23:35 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-24 | Sell | 1,768 | 305.38 | 539,912 | 2023-03-28 16:13:21 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-17 | Sell | 2,000 | 296.39 | 592,786 | 2023-03-21 16:21:13 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-03-16 | Sell | 2,746 | 300.59 | 825,423 | 2023-03-20 16:26:33 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 2023-03-10 | Sell | 4,754 | 291.98 | 1,388,054 | 2023-03-14 16:22:50 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2023-02-24 | Sell | 354 | 287.48 | 101,768 | 2023-02-28 17:11:24 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | 2023-02-24 | Sell | 5,034 | 287.47 | 1,447,144 | 2023-02-28 16:47:58 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | SVP & Chief Accounting Officer | 2023-02-24 | Sell | 1,207 | 287.55 | 347,072 | 2023-02-28 16:44:44 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | 2023-02-24 | Sell | 4,238 | 287.51 | 1,218,450 | 2023-02-28 16:40:33 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | 2023-02-22 | Sell | 2,401 | 294.33 | 706,679 | 2023-02-24 16:06:38 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2023-02-17 | Sell | 480 | 293.75 | 141,002 | 2023-02-22 16:48:42 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | 2023-02-17 | Sell | 2,402 | 293.75 | 705,596 | 2023-02-22 16:30:12 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | 2023-02-17 | Sell | 4,002 | 293.77 | 1,175,676 | 2023-02-22 16:25:25 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2023-02-14 | Sell | 320 | 298.52 | 95,527 | 2023-02-16 16:18:26 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-02-14 | Sell | 2,181 | 300.39 | 655,161 | 2023-02-16 16:16:05 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | 2023-02-14 | Sell | 6,398 | 298.68 | 1,910,962 | 2023-02-16 16:14:12 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | 2023-02-14 | Sell | 6,398 | 298.70 | 1,911,108 | 2023-02-16 16:11:01 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | 2023-02-10 | Sell | 275 | 298.99 | 82,223 | 2023-02-14 17:12:20 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-02-10 | Sell | 113 | 300.39 | 33,944 | 2023-02-14 17:08:54 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | 2023-02-10 | Sell | 4,887 | 298.92 | 1,460,816 | 2023-02-14 16:53:14 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | 2023-02-10 | Sell | 4,798 | 298.90 | 1,434,127 | 2023-02-14 16:49:25 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | 2023-02-06 | Sell | 1,304 | 306.00 | 399,022 | 2023-02-08 16:53:50 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | 2023-02-06 | Option Exercise | 1,304 | 187.53 | 244,539 | 2023-02-08 16:53:50 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Sanna Bastiano | EVP, Cell & Genetic Therapies | 2023-01-31 | Sell | 106 | 325.00 | 34,450 | 2023-02-02 16:18:08 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | SACHS BRUCE I | Directior | 2023-01-31 | Sell | 1,200 | 325.01 | 390,012 | 2023-02-02 16:14:45 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | SACHS BRUCE I | Directior | 2023-01-31 | Option Exercise | 1,200 | 72.14 | 86,568 | 2023-02-02 16:14:45 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | CARNEY LLOYD | Directior | 2023-01-30 | Sell | 2,700 | 320.52 | 865,406 | 2023-01-31 16:45:28 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Lee Yuchun | Directior | 2023-01-27 | Sell | 1,429 | 322.03 | 460,177 | 2023-01-31 16:42:11 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Lee Yuchun | Directior | 2023-01-27 | Option Exercise | 1,429 | 72.14 | 103,088 | 2023-01-31 16:42:11 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Lee Yuchun | Directior | 2023-01-25 | Sell | 8,000 | 316.15 | 2,529,175 | 2023-01-27 16:18:18 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Lee Yuchun | Directior | 2023-01-25 | Option Exercise | 8,000 | 72.14 | 577,120 | 2023-01-27 16:18:18 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | 2023-01-25 | Sell | 10,000 | 315.05 | 3,150,500 | 2023-01-27 16:13:21 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Lee Yuchun | Directior | 2023-01-23 | Sell | 6,129 | 312.46 | 1,915,044 | 2023-01-25 16:08:09 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Lee Yuchun | Directior | 2023-01-23 | Option Exercise | 6,129 | 72.14 | 442,146 | 2023-01-25 16:08:09 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Lee Yuchun | Directior | 2023-01-17 | Sell | 4,442 | 312.04 | 1,386,099 | 2023-01-19 16:07:54 |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | Lee Yuchun | Directior | 2023-01-17 | Option Exercise | 4,442 | 72.14 | 320,446 | 2023-01-19 16:07:54 |
